Participants must be a healthy adult 60 years of age and over with a low risk of being exposed to SARS-CoV-2.The purpose of this study is to assess the safety, tolerability, and immunogenicity of the investigational vaccine to prevent COVID-19 disease as compared to a placebo.
AMR Lexington is currently seeking healthy volunteers to support future clinical trials to combat COVID-19.
The purpose of this study is to show lot-to-lot consistency of the vaccine regimen by demonstrating that paired 2-dose vaccine regimens from 3 consecutively manufactured lots of an investigational Ebola vaccine elicit equivalent immune responses.
The purpose of this study is to assess the supportive role of an investigational dietary supplement when taken by subjects who are also taking previously failed antibiotics to treat an uncomplicated, community-acquired skin infections, including infections due to Methicillin-Resistant staphylococcus aureus (MRSA).
